Status:
UNKNOWN
Promoting Shared-decision Making in Opportunistic Screening for Prostate Cancer
Lead Sponsor:
Universidad Miguel Hernandez de Elche
Collaborating Sponsors:
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Hospital de Sant Pau
Conditions:
Decision Making, Shared
Prostate-Specific Antigen
Eligibility:
All Genders
Brief Summary
In this project, the investigators aim to evaluate the most appropriate design and implementation strategy of a decision-aid to promote shared-decision making in prostate cancer screening.
Detailed Description
Prostate cancer (PC) screening using Prostate Specific Antigen (PSA) has led to a reduction in advanced disease and disease-specific mortality. However, screening with PSA can also cause harm and is a...
Eligibility Criteria
Inclusion
- Patients:
- Men \>40 years old
- Men who have not had prostate cancer
- General practitioners:
- Primary care doctors working in the Valencian Community, Spain.
- Urologists:
- Urologists working in the Valencian Community, Spain.
Exclusion
- Patients: None
- General practitioners: None
- Urologists: None
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
1781 Patients enrolled
Trial Details
Trial ID
NCT05187949
Start Date
July 1 2022
End Date
December 1 2023
Last Update
May 17 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.